Docket Number:13A-1070515
Inventor:Nan-Shih Liao
IP Status:US 9597356 B2
Abstract:
This invention is the use of adoptive transfer of in vitro cultivated dendritic killer cells for treatment of cancer. Dendritic killer cells are natural killer cells. The dendritic killer cells cultivated according to this invention have anti-tumor activity and induce T cell activation.
Fields of Application:
Cancer immunotherapy
Advantages when compared to the existing technologies:
Higher safety and lower cost in comparison to current cancer immunotherapy antibody drug.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
